Today: 18 June 2026
Browse Category

Stock Market 25 February 2026

CervoMed shares rose after the company received a U.S. patent allowance for neflamapimod in pure dementia with Lewy bodies, with the patent expected to last until 2042. Corning shares rebounded, driven by investor focus on its optical-fiber and photonics exposure to AI data-center spending. Amazon climbed about 2.4% after reports it is in talks to sell its custom AI chips to outside data centers. Butterfly Network surged over 50% at one point after Midjourney built a full-body ultrasound scanner from Butterfly modules, highlighting a licensing and co-development deal that could bring Butterfly up to $74 million. SpaceX’s public-market debut has created tax and diversification challenges for tech workers with stock-heavy compensation. Taiwan’s Taiex closed at a record high, with TSMC gaining 1.05% and its U.S. ADR rising 6.3%, boosting chip stocks. Grab rose 2.6% amid higher Q1 profit and a $500 million buyback, though investors remain cautious. Strategy’s Stretch preferred stock traded below its $100 target, which is significant for the company’s bitcoin funding strategy. U.S. gas prices fell below $4, the lowest since March, after a U.S.-Iran interim deal aimed at reopening the Strait of Hormuz. Salesforce shares remained under pressure despite record results and strong AI-driven recurring revenue, with concerns about its $3.6 billion Fin deal and integration risks. CDT Equity shares surged after a private investment in Sarborg, though risks remain from a new convertible loan and upcoming Nasdaq listing. Hyperscale Data shares climbed around 8%, with trading linked to AI data center and Bitcoin updates. Pfizer fell 3.2% after announcing CFO Dave Denton’s departure, as investors focus on 2026 guidance and upcoming changes. The S&P 500, Nasdaq, and Dow all posted gains, while Brent crude dropped and the U.S. 10-year Treasury yield eased. Intel led chip stocks higher after news that Apple will team up with Intel on U.S. chip production. Apple shares gained after CEO Tim Cook said product price hikes are unavoidable due to higher chip costs. IBM fell 6.9% after Accenture’s weak sales forecast and concerns from IBM’s AI report about control over AI outcomes. QuantumScape rose 5.7% after Honda R&D agreed to a multi-year solid-state battery research program, though execution risk remains. Energy Fuels rose 10% after a conditional U.S. government loan commitment fo
AMD stock rises in premarket as Meta AI-chip pact puts 160 million-share warrant under a microscope

AMD stock rises in premarket as Meta AI-chip pact puts 160 million-share warrant under a microscope

AMD rose about 0.8% to $215.50 in premarket trading Wednesday after announcing a multi-year deal with Meta to supply up to 6 gigawatts of Instinct GPUs. Meta received a performance-based warrant for up to 160 million AMD shares, vesting in tranches tied to chip shipments and stock-price targets. Reuters reported the agreement could reach $60 billion over five years.
ImmunityBio stock jumps again in premarket as ANKTIVA sales surge puts IBRX in focus

ImmunityBio stock jumps again in premarket as ANKTIVA sales surge puts IBRX in focus

ImmunityBio shares rose 3.5% to $11.95 premarket Wednesday after reporting 2025 net product revenue of $113 million for Anktiva, up about 700% year over year. The company posted a 2025 net loss of $351.4 million and ended the year with $242.8 million in cash. Investors await a March FDA meeting on recombinant BCG. Director Barry J. Simon sold 175,000 shares last week under a prearranged plan.
25 February 2026
Brand Engagement Network (BNAI) stock jumps again in premarket after a 40% rally — what to watch at the open

Brand Engagement Network (BNAI) stock jumps again in premarket after a 40% rally — what to watch at the open

Brand Engagement Network shares rose 6.7% to $30.08 in premarket trading Wednesday after a 40.2% surge the previous session. The company recently ended a $50 million standby equity purchase agreement and is set to close a $1.518 million private placement in February. Trading volume hit 4.74 million shares Tuesday, with the stock moving between $20.72 and $29.00.
25 February 2026
Twilio stock steadies near $114 premarket as fresh 10-K shows profit swing, cash flow lift

Twilio stock steadies near $114 premarket as fresh 10-K shows profit swing, cash flow lift

Twilio reported 2025 net income of $33.8 million on $5.07 billion revenue in its annual 10-K, reversing a loss a year earlier. Shares hovered near $113.80 in premarket trading after closing Tuesday up 4.9%. The company listed 402,000 active customer accounts and $945.4 million in free cash flow. CFO Aidan Viggiano received 37,554 restricted stock units set to vest from March 2026.
TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook

TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook

TransMedics Group shares jumped 7.3% premarket to $147.88 after posting Q4 revenue of $160.8 million, up 32%, and setting a 2026 revenue forecast of $727–$757 million. Net income for the quarter reached $105.4 million, boosted by an $83.8 million tax benefit. Adjusted earnings were 57 cents per share, topping analyst estimates. Gross margin slipped to 58% as clinical service and freight costs rose.
MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI

MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI

MercadoLibre shares dropped over 6% in after-hours trading Tuesday after missing quarterly profit estimates, with net income at $559 million versus the $587 million expected. Heavy spending on credit and logistics squeezed margins, despite a 45% revenue jump to $8.8 billion. The company’s credit portfolio surged nearly 90% to $12.5 billion. Investors are watching for management’s outlook on margin recovery.
Diageo shares sink after dividend cut and outlook trim as new CEO resets guidance

Diageo shares sink after dividend cut and outlook trim as new CEO resets guidance

Diageo shares dropped about 6% in London after the company cut its dividend and lowered its annual outlook, citing weaker U.S. demand and pressure in China. First-half reported net sales fell 4% to $10.46 billion, with U.S. sales down 9.3% and tequila sales plunging over 23%. The interim dividend was reduced to 20 cents per share. Net debt stood at $21.7 billion as of December 31.
25 February 2026
AMD stock steadies before the open after Meta AI chip deal, 160 mln-share warrant

AMD stock steadies before the open after Meta AI chip deal, 160 mln-share warrant

AMD shares rose 0.4% in premarket trading after announcing a five-year AI chip supply deal with Meta worth up to $60 billion. The agreement gives Meta a warrant to buy up to 10% of AMD stock at $0.01 per share, tied to shipment and stock-price milestones. The deal comes hours before Nvidia’s earnings report, which investors are watching for AI chip demand signals.
Compass Group share price ticks higher today — what’s moving CPG stock in London

Compass Group share price ticks higher today — what’s moving CPG stock in London

Compass Group shares rose 0.6% to 2,197 pence by 0845 GMT Wednesday, after closing up 1.35% Tuesday and rebounding from a 2.62% drop Monday. The stock remains about 23% below its 52-week high, with trading volumes above average. Investors remain focused on AI risks and office demand, with about 20% of revenue tied to corporate clients. Compass will pay its dividend Feb. 26 and switch share trading to U.S. dollars April 1.
25 February 2026
Why Lloyds Banking Group share price is moving: buyback update meets rate-cut nerves

Why Lloyds Banking Group share price is moving: buyback update meets rate-cut nerves

Lloyds bought back 15 million shares on Feb. 24 at a volume-weighted average price of 102.27 pence, and 5 million shares the previous day at 104.60 pence, both for cancellation. The stock rose about 0.7% to 103.3 pence in early Wednesday trade after a 1.2% drop Tuesday. Investors are watching for the Bank of England’s March 19 rate decision and UK inflation data on March 25.
25 February 2026

Stock Market Today

  • CervoMed Shares Surge on Dementia Drug Patent, Market Pulls Back on Equity Offering
    June 18, 2026, 4:08 PM EDT. CervoMed shares surged initially to $7.75 after U.S. patent allowance for neflamapimod in pure dementia with Lewy bodies (DLB) was announced, potentially protecting the drug through 2042. The company plans a $10 million registered direct equity offering at $4 per share, causing the stock to retrace gains and settle at $4.14. CervoMed aims to advance its oral DLB drug to late-stage trials, addressing an unmet need with no current approved treatments in the U.S. or EU. The equity raise, arranged by H.C. Wainwright, will support ongoing development and general corporate uses. The market reacted to the balance of intellectual property value against dilution risk. CervoMed's recent private placement extends its cash runway to Q2 2027, as it seeks a Phase 3 partner for neflamapimod.

Latest articles

CervoMed rises on patent news, pares gains after $10M equity sale

CervoMed rises on patent news, pares gains after $10M equity sale

18 June 2026
CervoMed shares soared to $7.75 intraday after announcing a U.S. patent allowance for neflamapimod in “pure” dementia with Lewy bodies patients, with protection expected into 2042, but gave back most gains after a $10 million share sale at $4 each; stock last up 8.7% at $4.14 on volume over 105 million shares.
Corning stock jumps 10% as AI data-center fiber trade draws fresh bids

Corning stock jumps 10% as AI data-center fiber trade draws fresh bids

18 June 2026
Corning shares soared 10.3% to $193.45 Thursday, outpacing the market as investors focused on its AI data-center optical-fiber deals with Amazon and Nvidia; core Q1 sales rose 18% to $4.35 billion, but risks remain from weak consumer demand and a high P/E ratio of 92, with the lowest analyst target at $180.
Amazon Shares Edge Higher, AI Chip Push Puts Spotlight on AWS Spend

Amazon Shares Edge Higher, AI Chip Push Puts Spotlight on AWS Spend

18 June 2026
Amazon shares jumped 2.4% after reports it’s in talks to sell its custom AI chips to other companies’ data centers, signaling a potential new revenue stream beyond AWS and raising investor hopes that Amazon’s heavy AI spending could soon deliver faster returns.
Go toTop